Arcus Biosciences, Inc. (RCUS) came out with a quarterly loss of $1.09 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $0.93 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly…

Click here to view the original article.